QA Safety Features V.15 released

The Commission has released v. 15 of the Q&A of safety features for medicinal products for human use, published by the European Commission on 15th  July 2019.

New questions 3.7, 5.10 and 8.10 have been added.

Question 3.7 answers who verifies and decommissions medicines used in clinical trials.

Question 5.10 explains how wholesalers can check that medicines they receive without safety features have been batch released prior to 9th February 2019.

Question 8.10 covers parallel traders and repackaging for Greece and Italy during the transition period.

In addition to this, question 1.6 has had wording revised, this question covers safety features on medicinal products intended for research and development trials.

For ease of reference, we’ve also attached a copy highlighting the changes:

You can find the full document on the Commission website: https://ec.europa.eu/health/human-use/falsified_medicines_en